Philips' (PHG) Diagnosis & Treatment Segment Drives Growth

Philips expects 2024 comparable sales growth for the underlined segment in the band of 3-5%. The consensus mark for 2024 earnings is pegged at $1.54 per share, indicating an increase of 14.1% year over year. The figure has moved upward by 0.7% in the past 30 days. Zacks Rank & Stocks to Consider Some better-ranked stocks in the broader medical market sector are DaVita (DVA) , ICON (ICLR) and Encompass Health (EHC) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zac ...